646
Views
1
CrossRef citations to date
0
Altmetric
Review

The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis

ORCID Icon, ORCID Icon, &
Pages 219-230 | Received 02 Oct 2023, Accepted 07 Feb 2024, Published online: 19 Feb 2024

References

  • Wunrow HY, Bender RG, Vongpradith A, et al. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol [Internet]. 2023 Aug;22(8):685–711. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442223001953
  • Wang H, Zhao S, Wang S, et al. Global magnitude of encephalitis burden and its evolving pattern over the past 30 years. J Infect. 2022 Jun 1;84(6):777–787. doi: 10.1016/j.jinf.2022.04.026
  • Rajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis [Internet]. 2022;22(12):1748–1755. doi: 10.1016/S1473-3099(22)00499-6
  • Dodd PJ, Osman M, Cresswell FV, et al. The global burden of tuberculous meningitis in adults: a modelling study. PLoS Glob Public Health. 2021 Dec 8;1(12):e0000069. doi: 10.1371/journal.pgph.0000069
  • Zunt JR, Kassebaum NJ, Blake N, et al. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018 Dec 1;17(12):1061–1082. doi: 10.1016/S1474-4422(18)30387-9
  • Sulaiman T, Salazar L, Hasbun R. Acute versus subacute community-acquired meningitis: analysis of 611 adult patients. Open Forum Infect Dis. 2016;3(suppl_1). doi: 10.1093/ofid/ofw172.878
  • Tenforde MW, Mokomane M, Leeme T, et al. Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: results from the Botswana national meningitis survey. J Infect. 2019;79(3):212–219. doi: 10.1016/j.jinf.2019.06.013
  • Dittrich S, Rattanavong S, Lee SJ. et al. Orientia, rickettsia, and Leptospira pathogens as causes of CNS infections in Laos: a prospective study. Lancet Glob Health. 2015 Feb;3(2):e104–12
  • Lingani C, Bergeron-Caron C, Stuart JM, et al. Meningococcal meningitis surveillance in the African meningitis belt, 2004–2013. Clin Infect Dis. 2015 Nov 15;61(suppl_5):S410–5. doi: 10.1093/cid/civ597
  • Siddiqi OK, Ghebremichael M, Dang X, et al. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clinl Infect Dis. 2014 Jun 15;58(12):1771–1777. doi: 10.1093/cid/ciu191
  • Ellis J, Bangdiwala AS, V CF, et al. The changing epidemiology of HIV-Associated adult meningitis, Uganda 2015–2017. Open Forum Infect Dis. 2019 Oct 1;6(10). doi: 10.1093/ofid/ofz419
  • Tenforde MW, Gertz AM, Lawrence DS, et al. Mortality from HIV‐associated meningitis in sub‐Saharan Africa: a systematic review and meta‐analysis. J Int AIDS Soc. 2020 Jan;23(1). doi: 10.1002/jia2.25416
  • DeBiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17(4):903–925. doi: 10.1128/CMR.17.4.903-925.2004
  • McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr 1;72(4):405–438. doi: 10.1016/j.jinf.2016.01.007
  • Karakousis A, Tan L, Ellis D. et al. An assessment of the efficiency of fungal DNA extraction methods for maximizing the detection of medically important fungi using PCR. J Microbiol Methods. 2006 Apr;65(1):38–48
  • Bridge S, Huppler K, Nerima C, et al. Evaluation of the BioFire Ò FilmArray Ò Meningitis/Encephalitis panel in an adult and pediatric Ugandan population. J Med Mycol. 2021;31(3):101170. doi: 10.1016/j.mycmed.2021.101170
  • Cresswell FV, Tugume L, Bahr NC, et al. Xpert MTB/RIF ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis. 2020 Mar 1;20(3):308–317. doi: 10.1016/S1473-3099(19)30550-X
  • Scarborough M, Thwaites GE. The diagnosis and management of acute bacterial meningitis in resource-poor settings. Lancet Neurol. 2008;7(7):637–648. doi: 10.1016/S1474-4422(08)70139-X
  • Jarvis JN, Meintjes G, Williams A, et al. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010;10(1):10. doi: 10.1186/1471-2334-10-67
  • Tenforde MW, Meintjes G, Mokomane M, et al. Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis. AIDS. 2019 Jul 15;33(9):1539–1541.
  • Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clinl Infect Dis. 2004;1October129(9):1267–1284. doi: 10.1086/425368
  • Poplin V, Boulware DR, Bahr NC. Methods for rapid diagnosis of meningitis etiology in adults. Biomarker Med. 2020;14(6):459–479. doi: 10.2217/bmm-2019-0333
  • Jarvis JN, Bicanic T, Loyse A. et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clinl Infect Dis. 2014 Mar;58(5):736–745
  • Bohr V, Rasmussen N, Hansen B. et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy part III of a three-part series. J Infect. 1983 Nov;7(3):193–202
  • Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001 Nov;108(5):1169–1174. doi: 10.1542/peds.108.5.1169
  • Tschopp J, Brunel AS, Spertini O, et al. High false-positive rate of (1,3)-β-D-Glucan in onco-hematological patients receiving immunoglobulins and therapeutic antibodies. Clinl Infect Dis. 2022 Aug 25;75(2):330–333. doi: 10.1093/cid/ciab1028
  • Kanamori H, Kanemitsu K, Miyasaka T, et al. Measurement of (1-3)-.BETA.-D-Glucan derived from different gauze types. Tohoku J Exp Med. 2009;217(2):117–121. doi: 10.1620/tjem.217.117
  • Davis C, Wheat LJ, Myint T, et al. Efficacy of cerebrospinal fluid beta-D-glucan diagnostic testing for fungal meningitis: a systematic review. J Clin Microbiol [Internet]. 2020;58(4). doi: 10.1128/jcm.02094-19
  • Forster J, Hoenigl M, Suerbaum S, et al. Serologic biomarkers in Candida and aspergillus infections of the central nervous system: a comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid. Mycoses. 2022 Jul 1;65(7):709–714.
  • Song J, Kim SH, Jung YR, et al. 10-year retrospective review of the etiologies for meningitis with elevated adenosine deaminase in cerebrospinal fluid: etiologies other than TB. Front Cell Infect Microbiol. 2022 Jul 5;12. doi: 10.3389/fcimb.2022.858724
  • Ekermans P, Dusé A, George J. The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis. BMC Infect Dis. 2017 Dec 31;17(1):104.
  • Mishra O. Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children. J Trop Pediatr. 1996 Jun 1;42(3):129–132.
  • Macrae C, Ellis J, Keddie SH, et al. Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review. BMC Infect Dis. 2023 Apr 6;23(1):209. doi: 10.1186/s12879-023-08135-w
  • Temfack E, Rim JJB, Spijker R, et al. Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and meta-analysis of diagnostic test accuracy studies. Clinl Infect Dis. 2021 Apr 8;72(7):1268–1278. doi: 10.1093/cid/ciaa1243
  • Tadeo KK, Nimwesiga A, Kwizera R, et al. Evaluation of the diagnostic performance of a semiquantitative cryptococcal antigen point-of-care assay among HIV-Infected persons with cryptococcal meningitis. J Clin Microbiol. 2021 Jul 1;59(8). doi: 10.1128/JCM.00860-21
  • Feagins AR, Ronveaux O, Taha MK. et al. Next generation rapid diagnostic tests for meningitis diagnosis. J Infect. 2020 Nov;81(5):712–718
  • Haddar C, Terrade A, Verhoeven P. et al. Validation of a new rapid detection test for detection of Neisseria meningitidis A/C/W/X/Y antigens in cerebrospinal fluid. J Clin Microbiol. 2020 Feb;58(3):e01699–19
  • WHO. Meeting report of a technical expert consultation: non-inferiority analysis of xpert MTB/RIF ultra compared to xpert MTB/RIF [Internet]. 2017. Available from: http://apps.who.int/bookorders
  • Heemskerk AD, Donovan J, Thu DDA, et al. Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluid. J Infect. 2018 Dec 1;77(6):509–515. doi: 10.1016/j.jinf.2018.09.003
  • Seid G, Alemu A, Dagne B, et al. Microbiological diagnosis and mortality of tuberculosis meningitis: systematic review and meta-analysis. PLoS One. 2023 Feb 1;18(2):e0279203.
  • Chen P, Shi M, Feng GD. et al. A highly efficient Ziehl-Neelsen stain: Identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol. 2012 Apr;50(4):1166–1170
  • Stadelman AM, Ssebambulidde K, Buller A, et al. Cerebrospinal fluid AFB smear in adults with tuberculous meningitis: a systematic review and diagnostic test accuracy meta-analysis. SSRN Electron J. 2021. doi: 10.2139/ssrn.3770634
  • Donovan J, Thu DDA, Phu NH, et al. Xpert MTB/RIF ultra versus xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis. 2020 Mar 1;20(3):299–307. doi: 10.1016/S1473-3099(19)30649-8
  • Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2018 Jan 1;18(1):68–75. doi: 10.1016/S1473-3099(17)30474-7
  • Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF ultra and xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD012768. doi: 10.1002/14651858.CD012768.pub3. PMID: 33448348; PMCID: PMC8078545.
  • Donovan J, Cresswell FV, Thuong NTT, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward. Clin Infec Dis. 2020 Nov 5;71(8):2002–2005. doi: 10.1093/cid/ciaa473
  • Broger T, Nicol MP, Szekely R, et al. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: a meta-analysis of individual in- a nd outpatient data. PLoS Med. 2020;17(5):1–16. doi: 10.1371/journal.pmed.1003113
  • Siddiqi OK, Birbeck GL, Ghebremichael M, et al. Prospective cohort study on performance of cerebrospinal fluid (CSF) xpert MTB/RIF, CSF lipoarabinomannan (LAM) lateral flow assay (LFA), and urine LAM LFA for diagnosis of tuberculous meningitis in Zambia. J Clin Microbiol. 2019;57(8). doi: 10.1128/JCM.00652-19
  • Quinn CM, Kagimu E, Okirworth M, et al. Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in adults with human immunodeficiency virus. Clinl Infect Dis. 2021;73(9):e3428–34. doi: 10.1093/cid/ciaa1910
  • Sharma K, Sharma M, Modi M, et al. Comparative analysis of TruenatE MTB plus and XpertW Ultra in diagnosing tuberculous meningitis. Int J Tuberc Lung Dis. 2021 Aug 1;25(8):626–631. doi: 10.5588/ijtld.21.0156
  • Bossolasco S, Calori G, Moretti F, et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-Associated progressive multifocal leukoencephalopathy [Internet]. Available from: https://academic.oup.com/cid/article/40/5/738/365769
  • Nakamichi K, Kawamoto M, Ishii J. et al. Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy. BMC neurol. 2019 Oct 25;19(1). doi: 10.1186/s12883-019-1476-2
  • Ferretti F, Bestetti A, Yiannoutsos CT, et al. Diagnostic and prognostic value of JC virus DNA in plasma in progressive multifocal leukoencephalopathy. Clinl Infect Dis. 2018 Jun 18;67(1):65–72. doi: 10.1093/cid/ciy030
  • Tan IL, McArthur JC, Clifford DB, et al. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology. 2011 Sep;77(11):1061–1067. doi: 10.1212/WNL.0b013e31822e55e7
  • Berger JR, Aksamit AJ, Clifford DB, et al. VIEWS & REVIEWS PML diagnostic criteria consensus statement from the AAN neuroinfectious disease section [Internet]. 2013. Available from: www.neurology.org
  • Miskin DP, Ngo LH, Koralnik IJ. Diagnostic delay in progressive multifocal leukoencephalopathy. Ann Clin Transl Neurol. 2016;3(5):386–391. doi: 10.1002/acn3.301
  • Sharma SK, Soneja M, Ranjan S, et al. Progressive multifocal leucoencephalopathy in HIV/AIDS: observational study from a tertiary care centre in northern India. Indian J Med Res. 2013;138(JUL 2013):72–77.
  • Arora S, Ahmad FMH, Deshwal R, et al. Study of clinical profile and outcomes in progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients in the highly active antiretroviral therapy era - an observational study. Indian J Sex Transm Dis AIDS. 2022;43(2):156–160. doi: 10.4103/ijstd.IJSTD_29_18
  • Vidal JE, de OA, MCDS F, et al. Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2008 Aug;50(4):209–212. doi: 10.1590/S0036-46652008000400004
  • Schutte CM, Ranchhod N, Kakaza M, et al. AIDS-related progressive multifocal leukoencephalopathy (PML): a retrospective study from Pretoria, South Africa. S Afr Med J. 2013;103(6):399–401. doi: 10.7196/SAMJ.6386
  • Sim BZ, Smith LK, Yarwood T, et al. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab. AIDS. 2022 Mar 1;36(3):483–485.
  • Safarpour H, Cevik M, Zarean M, et al. Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV. AIDS. 2020 Mar 1;34(3):469–474. doi: 10.1097/QAD.0000000000002424
  • Bokharaei-Salim F, Esteghamati A, Khanaliha K, et al. Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients. J Parasitic Dis. 2020 Mar 1;44(1):159–165. doi: 10.1007/s12639-019-01176-6
  • Wang ZD, Wang SC, Liu HH, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4(4):e177–88. doi: 10.1016/S2352-3018(17)30005-X
  • Liu Q, Wang ZD, Huang SY, et al. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites Vectors. 2015 Dec 28;8(1):292. doi: 10.1186/s13071-015-0902-6
  • Roux G, Varlet-Marie E, Bastien P, et al. Evolution of toxoplasma-PCR methods and practices: a French national survey and proposal for technical guidelines. Int J Parasitol. 2018;48(9–10):701–707. doi: 10.1016/j.ijpara.2018.03.011
  • Wesołowski R, Pawłowska M, Smoguła M, et al. Advances and challenges in diagnostics of toxoplasmosis in HIV-Infected patients. Pathogens. 2023 Jan 9;12(1):110. doi: 10.3390/pathogens12010110
  • Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(10):766–774. doi: 10.2471/BLT.10.085233
  • Mackenzie JS, Williams DT, van den Hurk AF, et al. Japanese encephalitis virus: the emergence of genotype IV in Australia and its potential endemicity. Viruses. 2022 Nov 9;14(11):2480.
  • Bharucha T, Sengvilaipaseuth O, Vongsouvath M, et al. Development of an improved RT-qPCR assay for detection of Japanese encephalitis virus (JEV) RNA including a systematic review and comprehensive comparison with published methods. PLoS One. 2018 Mar 1;13(3):e0194412. doi: 10.1371/journal.pone.0194412
  • Bharucha T, Shearer FM, Vongsouvath M, et al. A need to raise the bar — A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research. Inter J Infect Dis. 2020 Jun 1;95:444–456.
  • Rowley J, Vander HS, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548–562P. doi: 10.2471/BLT.18.228486
  • Marks M, Jarvis JN, Howlett W, et al. Neurosyphilis in Africa: a systematic review. PLoS Negl Trop Dis. 2017 Aug 1;11(8):e0005880. doi: 10.1371/journal.pntd.0005880
  • de Voux A, Kidd S, Torrone EA. Reported cases of neurosyphilis among early syphilis cases—United States, 2009 to 2015. Sex Transm Dis. 2018 Jan;45(1):39–41. doi: 10.1097/OLQ.0000000000000687
  • Ropper AH, Neurosyphilis, Longo DL editor, et al. Neurosyphilis. N Engl J Med [Internet]. 2019 Oct 3;381(14):1358–1363. doi: 10.1056/NEJMra1906228
  • Marks M, Lawrence D, Kositz C. et al. Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review. Sex Transm Infect. 2018 Dec;94(8):585–588
  • Gonzalez H, Koralnik IJ, Huhn GD, et al. A dual-platform point-of-care test for neurosyphilis diagnosis. Sex Transm Dis. 2021 May 1;48(5):353–356. doi: 10.1097/OLQ.0000000000001308
  • Leber A, Everhart K, Balada-Llasat J, et al. Multi-center clinical evaluation of a multiplex Meningitis/Encephalitis PCR panel for simultaneous detection of bacteria, yeast, and viruses in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251–2261. doi: 10.1128/JCM.00730-16
  • Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):281–290. doi: 10.1016/j.cmi.2019.11.016
  • Humisto A, Antikainen J, Holma T, et al. Evaluation of the novel CE-IVD-Marked multiplex PCR QIAstat-dx Meningitis/Encephalitis panel. Microbiol Spectr. 2023;11(3):1–11. doi: 10.1128/spectrum.05144-22
  • QIAGEN. Sample to insight QIAstat-dx ® Meningitis/Encephalitis (ME) panel instructions for use (handbook) 6. 2022.
  • Rhein J, Bahr NC, Hemmert AC, et al. Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda. Diagn Microbiol Infect Dis. 2016 Mar;84(3):268–273. doi: 10.1016/j.diagmicrobio.2015.11.017
  • Bårnes GK, Gudina EK, Berhane M, et al. New molecular tools for meningitis diagnostics in Ethiopia - a necessary step towards improving antimicrobial prescription. BMC Infect Dis. 2018;18(1):1–14. doi: 10.1186/s12879-018-3589-4
  • Debbagh F, Harrar S, Babokh F, et al. The contribution of multiplex polymerase chain reaction in the diagnosis of central nervous system infections in intensive care units. Cureus. 2023;15(2). doi: 10.7759/cureus.35338
  • Tarai B, Das P. FilmArray® meningitis/encephalitis (ME) panel, a rapid molecular platform for diagnosis of CNS infections in a tertiary care hospital in North India: one-and-half-year review. Neurol Sci. 2019;40(1):81–88. doi: 10.1007/s10072-018-3584-y
  • Peñata A, Mesa S, Leal A, et al. Molecular diagnosis of meningitis and meningoencephalitis with an automated real-time multiplex polymerase chain reaction in a tertiary reference complex in medellín, Colombia. Rev Inst Med Trop Sao Paulo. 2020;62:e77. doi: 10.1590/s1678-9946202062077
  • Brisset J, Angendu Baki K, Watier L, et al. Non-traumatic coma in young children in Benin: are viral and bacterial infections gaining ground on cerebral malaria? Infect Dis Poverty. 2022;11(1):1–10. doi: 10.1186/s40249-022-00956-2
  • Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clinl Infect Dis. 2018;66(5):778–788. doi: 10.1093/cid/cix881
  • Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380(24):2327–2340. doi: 10.1056/NEJMoa1803396
  • Hong NTT, Anh NT, Mai NTH, et al. Performance of metagenomic next-generation sequencing for the diagnosis of viral meningoencephalitis in a resource-limited setting. Open Forum Infect Dis. 2020;7(3):1–10. doi: 10.1093/ofid/ofaa046
  • Ramachandran PS, Ramesh A, Creswell FV, et al. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics. Nat Commun. 2022;13(1):1–12. doi: 10.1038/s41467-022-29353-x
  • Houlihan CF, Bharucha T, Breuer J. Advances in molecular diagnostic testing for central nervous system infections. Curr Opin Infect Dis. 2019;32(3):244–250. doi: 10.1097/QCO.0000000000000548
  • Hong NTT, Anh NT, Mai NTH, et al. Performance of metagenomic next-generation sequencing for the diagnosis of viral meningoencephalitis in a resource-limited setting. Open Forum Infect Dis. 2020 Mar 1;7(3). doi: 10.1093/ofid/ofaa046
  • Wick RR, Judd LM, Holt KE, et al. Assembling the perfect bacterial genome using oxford nanopore and Illumina sequencing. PLoS Comput Biol. 2023 Mar 1;19(3):e1010905. doi: 10.1371/journal.pcbi.1010905
  • Hu T, Chitnis N, Monos D, et al. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82(11):801–811. doi: 10.1016/j.humimm.2021.02.012